Anqi Cao

Dr. Anqi Cao

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2025 in Molecules
Verified
Journal Article
Open access
PDF file
ACAnqi Cao
Anqi Cao
煜李煜荣 李
煜荣 李
YFYanqiao Feng
Yanqiao Feng
XWXiaoquan Wang
Xiaoquan Wang
WWWenyu Wei
Wenyu Wei
JQJunmin Quan
Junmin Quan
Psoriasis is a chronic inflammatory skin disease characterized by abnormal proliferation of keratinocytes and infiltration of inflammatory cells. Significant challenges remain in developing effective and safe targeted therapies for psoriasis. Here, we reported the discovery of novel cystamine derivatives for the treatment of psoriasis. These compounds effectively attenuated LPS-induced inflammation in vitro, and the optimal candidate CS1 ameliorated imiquimod-induced psoriasis-like inflammation in mice. Mechanistically, CS1 bound and inhibited the deacetylase HDAC6, subsequently inhibited the AKT, MAPK, and STAT3 pathways, attenuated the hyperproliferation and altered differentiation of keratinocytes and reduced the infiltration of immune cells. These findings suggest that HDAC6 may serve as a potential target for drug development in the treatment of psoriasis.

17 September 2026 in Frontiers in Natural Products
Verified
Journal Article
Open access
PDF file
ACAnqi Cao
Anqi Cao
XWXiaohui Wang
Xiaohui Wang
SQSiwei Quan
Siwei Quan
YQYingfa Qin
Yingfa Qin
WCWenjiang Cai
Wenjiang Cai
JQJunmin Quan
Junmin Quan
Ultraviolet A (UVA) radiation is a primary extrinsic driver of skin photoaging, yet effective marine-derived photoprotective countermeasures remain underexplored. The Akoya pearl oyster ( Pinctada fucata martensii, Pinctada martensii ) mucus represents a largely underexplored source of water-soluble marine natural products. In the present study, a low-molecular-weight aqueous fraction (designated AKN) was prepared via direct aqueous extraction and 3 kDa ultrafiltration without enzymatic hydrolysis, preserving the native constituent profile. AKN was systematically profiled using orthogonal untargeted LC–MS and targeted compositional analyses, with taurine and betaine accounting for 8.0% and 4.1% of the dry weight, respectively. Its biological effects were evaluated in UVA-exposed L929 murine fibroblasts, LPS-stimulated BV2 murine microglial cells, and a UVA-induced BALB/c mouse skin photoaging model, using ergothioneine (EGT) as a positive control. In cellular assays, AKN markedly suppressed the expression of key senescence regulators ( p16, p21, p53 ), attenuated pro-inflammatory mediators ( Tnf, Il6, Il1b ), and reduced intracellular reactive oxygen species. In mouse skin, topical AKN restored Col1a1 transcription and improved histological architecture by suppressing epidermal hyperplasia and collagen depletion, with 4 mg/mL AKN providing pronounced protection alongside 4 mg/mL ergothioneine. Overall, these findings establish P. martensii mucus as a promising source of natural, hydrolysis-free photoprotective agents and support further bioassay-guided identification of its primary active constituents.